Table 2. Interaction between surgical parameters and treatment modalities in stage T1N0M0 SCLC.
Variables | Oligo-modality cohort (n=146) | Bi-modality cohort (n=119) | Tri-modality cohort (n=72) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | Pa | HR | 95% CI | Pa | HR | 95% CI | Pa | |||
Resection type | |||||||||||
Sublobectomy | Reference | Reference | Reference | ||||||||
Lobectomy | 1.058 | 0.640–1.751 | 0.826 | 0.569 | 0.315–1.027 | 0.061 | 0.385 | 0.163–0.909 | 0.030 | ||
ELN | |||||||||||
≤7 | Reference | Reference | Reference | ||||||||
>7 | 0.704 | 0.436–1.136 | 0.151 | 0.660 | 0.383–1.136 | 0.134 | 0.722 | 0.365–2.010 | 0.857 |
a, univariate Cox analysis. SCLC, small-cell lung cancer; ELN, examined lymph nodes; HR, hazard ratio; CI, confidence interval.